Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process
- PMID: 18771457
- PMCID: PMC3119470
- DOI: 10.1111/j.1532-5415.2008.01916.x
Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process
Abstract
Thousands of Americans are injured or die each year from adverse drug reactions, many of which are preventable. The burden of harm conveyed by the use of medications is a significant public health problem, and therefore, improving the medication-use process is a priority. Recent and ongoing efforts to improve the medication-use process have focused primarily on improving medication prescribing, and not much emphasis has been put on improving medication discontinuation. A formalized approach for rationally discontinuing medications is a necessary antecedent to improving medication safety and improving the nation's quality of care. This article proposes a conceptual framework for revising the prescribing stage of the medication-use process to include discontinuing medications. This framework has substantial practice and research implications, especially for the clinical care of older persons, who are particularly susceptible to the adverse effects of medications.
Figures
Similar articles
-
[Most common cases of the unreasonable medication use].Medicina (Kaunas). 2003;39(6):610-6. Medicina (Kaunas). 2003. PMID: 12829887 Lithuanian.
-
Rules for improving pharmacotherapy in older adult patients: part 1 (rules 1-5).South Med J. 2015 Feb;108(2):97-104. doi: 10.14423/SMJ.0000000000000243. South Med J. 2015. PMID: 25688894 Review.
-
Algorithm of medication review in frail older people: Focus on minimizing the use of high-risk medications.Geriatr Gerontol Int. 2016 Sep;16(9):1002-13. doi: 10.1111/ggi.12589. Epub 2015 Sep 3. Geriatr Gerontol Int. 2016. PMID: 26338275 Review.
-
International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action.Drugs Aging. 2018 Jul;35(7):575-587. doi: 10.1007/s40266-018-0554-2. Drugs Aging. 2018. PMID: 30006810 Free PMC article.
-
Improving medication prescribing and utilization in the nursing home.J Am Geriatr Soc. 1990 May;38(5):542-52. doi: 10.1111/j.1532-5415.1990.tb02406.x. J Am Geriatr Soc. 1990. PMID: 2185295 Review.
Cited by
-
The Health Costs of Cost Sharing.Q J Econ. 2024 May 3;139(4):2037-2082. doi: 10.1093/qje/qjae015. eCollection 2024 Nov. Q J Econ. 2024. PMID: 39391632
-
An Internationally Derived Process of Healthcare Professionals' Proactive Deprescribing Steps and Constituent Activities.Pharmacy (Basel). 2024 Sep 9;12(5):138. doi: 10.3390/pharmacy12050138. Pharmacy (Basel). 2024. PMID: 39311129 Free PMC article.
-
Oral Lesion Management in Juvenile SLE with Hepatosplenomegaly.Int Med Case Rep J. 2024 Jul 23;17:695-702. doi: 10.2147/IMCRJ.S476377. eCollection 2024. Int Med Case Rep J. 2024. PMID: 39076507 Free PMC article.
-
Clinician and Family Caregiver Perspectives on Deprescribing Chronic Disease Medications in Older Nursing Home Residents Near the End of Life.Drugs Aging. 2024 Apr;41(4):367-377. doi: 10.1007/s40266-024-01110-3. Epub 2024 Apr 4. Drugs Aging. 2024. PMID: 38575748 Free PMC article.
-
CancelRx case study: implications for clinic and community pharmacy work systems.BMC Health Serv Res. 2023 Dec 6;23(1):1360. doi: 10.1186/s12913-023-10396-9. BMC Health Serv Res. 2023. PMID: 38057835 Free PMC article.
References
-
- Hanlon JT, Lindblad CI, Maher RL, et al. Geriatric pharmacotherapy. In: Tallis RC, Fillit HM, editors. Brocklehurst's textbook of geriatric medicine and gerontology. New York: Churchill Livingstone; 2003. pp. 1289–1296.
-
- Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA. 1998;279:1200–1205. - PubMed
-
- Kohn LT, Corrigan JM, Donaldson MS, editors. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 2000. - PubMed
-
- Preventing Medication Errors. Washington, DC: National Academies Press; 2006. Institute of Medicine.
-
- Bates DW, Cullen DJ, Laird N, et al. ADE Prevention Study Group. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA. 1995;274:29–34. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
